EQL Pharma is a fast growing European generic and speciality pharmaceutical company. We are completely market driven and do not have a particular therapeutic area focus.
We are actively searching to evaluate and license new original drugs and generica to distribute to our markets.
EQL Pharma’s goal is to identify unmet or under served markets and find therapeutic and pipeline compounds that will capture these markets using its world-class expertise in business development.
We only have prescription products in our portfolio and do not have our own research nor clinical development. We license product dossiers or pay contract research organizations to perform bioequivalence or other studies to complete new product dossiers, for the territories we are operating in.